Sabine Specht

5PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsNeurology and neuromuscular diseasesBiologically active moleculesEnvironmental epidemiologyMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 18, 2026
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.

Said Jongo, Eveline Ackermann, Gloria Nyaulingo

|Oct 13, 2021
Onchocerciasis drug development: from preclinical models to humans.

Adela Ngwewondo, Ivan Scandale, Sabine Specht

|Apr 30, 2021
Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.

Marta S Palmeirim, Sabine Specht, Ivan Scandale

|Mar 24, 2021
Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.

Jean-Yves Gillon, Jeremy Dennison, Frans van den Berg

|Jan 17, 2019
Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds.

Marc P Hübner, Alexandra Ehrens, Marianne Koschel

Pageof 1

Frequent Collaborators

2 joint publications

Jennifer Keiser

2 joint publications

Ivan Scandale

1 joint publications

Marc P Hübner

1 joint publications

Ludo Quirynen